COLUMBUS, GA, UNITED STATES, March 3, 2026 /EINPresswire.com/ -- OBGYN Specialists of Columbus is helping women better ...
What is Inluryo, and who can benefit from it? Learn about this newly approved breast cancer treatment and how it works.
What began as a single clinic in Colorado has evolved into a well-regarded provider of hormone optimization and replacement care, now serving more than 10,000 patients.
The portfolio meaningfully outperformed the MSCI EAFE Small Cap Growth Index but modestly lagged the blend MSCI ACWI ex USA SMID Index. Read more here.
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results